Table 8.

Comparison of the cumulative days of each symptom during the intake period (middle-aged participants).

Symptoms	Group	1–4 W			1–8 W			1–12 W
		Without	With	p-value	Without	With	p-value	Without	With	p-value
Runny nose	Placebo	1,485	223	<0.001*	2,898	518	<0.001*	4,367	757	<0.001*
	LG2055	1,526	350		3,069	683		4,662	966
Nasal congestion	Placebo	1,539	169	0.080	3,041	375	0.042*	4,527	597	<0.001*
	LG2055	1,722	154		3,395	357		5,112	516
Sneezing	Placebo	1,577	131	0.039*	3,039	377	<0.001*	4,519	605	<0.001*
	LG2055	1,765	111		3,449	303		5,131	497
Sore throat	Placebo	1,589	119	<0.001*	3,169	247	<0.001*	4,775	349	<0.001*
	LG2055	1,654	222		3,398	354		5,095	533
Hoarseness	Placebo	1,635	73	<0.001*	3,261	155	<0.001*	4,905	219	<0.001*
	LG2055	1,842	34		3,666	86		5,470	158
Cough	Placebo	1,570	138	<0.001*	3,155	261	<0.001*	4,722	402	<0.001*
	LG2055	1,783	93		3,587	165		5,371	257
Headache	Placebo	1,619	89	0.703	3,231	185	0.002*	4,843	281	<0.001*
	LG2055	1,784	92		3,606	146		5,421	207
General malaise	Placebo	1,646	62	0.269	3,271	145	0.953	4,905	219	0.329
	LG2055	1,794	82		3,594	158		5,409	219
Chills	Placebo	1,671	37	0.385	3,327	89	0.400	5,009	115	0.643
	LG2055	1,826	50		3,666	86		5,510	118
Feverishness	Placebo	1,690	18	0.137	3,380	36	0.469	5,069	55	0.999
	LG2055	1,865	11		3,719	33		5,567	61
Fatigue	Placebo	1,588	120	0.607	3,174	242	0.544	4,745	379	0.151
	LG2055	1,735	141		3,500	252		5,252	376
Feeling unwell	Placebo	1,666	42	0.751	3,325	91	0.882	5,005	119	0.079
	LG2055	1,826	50		3,655	97		5,466	162

^*Significant difference between the two groups (p < 0.05).